Trials
Search / Trial NCT06424509

Effects of Psychiatric Admissions on Self-harm and Suicide in People With Borderline Personality Disorder

Launched by LUND UNIVERSITY · May 16, 2024

Apply for Trial

Trial Information

Current as of February 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Psychiatric clinic in Sweden authorized to administer compulsory care for adults. Each clinic per specific calendar year will represent one participant, identified by the clinic's name and the respective year (e.g., Umeå2010, Linköping2013, Malmö2022).
  • Exclusion Criteria:
  • • No authorization to administer compulsory care for adults

Trial Officials

Sofie Westling, MD, PhD

Principal Investigator

Lund University

About Lund University

Lund University, a prestigious research institution in Sweden, is renowned for its commitment to advancing scientific knowledge and innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at addressing critical health challenges. Leveraging its state-of-the-art facilities and a diverse network of expert researchers, Lund University strives to translate research findings into effective therapeutic solutions, ultimately improving patient outcomes and enhancing public health. Through its dedication to ethical research practices and patient safety, Lund University plays a pivotal role in the global clinical research landscape.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0